Why the study?
Tenosynovitis frequently associates with rheumatoid arthritis and can precede inflammatory arthritis, suggesting it may serve as an important biomarker and treatable target in the pre-rheumatoid arthritis stage.
Does detecting and treating tenosynovitis prevent the progression to rheumatoid arthritis in predisposed individuals?
Does detecting and treating tenosynovitis prevent the progression to rheumatoid arthritis in predisposed individuals?
Tenosynovitis is a major trait of rheumatoid arthritis that can precede clinical inflammatory arthritis, and its early detection and treatment may prevent progression to clinical RA.
Answers are grounded in this paper and cite their sources.
Tenosynovitis may aid pre-RA identification; leaves open whether early treatment prevents progression.
Rheumatoid arthritis (RA) has long been characterized by synovitis and bone erosions typically developing symmetrically in small joints. However, recent advances in imaging modalities have indicated frequent association of tenosynovitis with RA, and some consider tenosynovitis to be not just a complication but a major trait of RA. Furthermore, as there are cases with tenosynovitis preceding the clinical detection of inflammatory arthritis in predisposed individuals, tenosynovitis may constitute an important biomarker in defining the pre-RA phase of disease development. Tenosynovitis itself must be treated as it causes functional impairment and physical as well as socioeconomic burden, and its treatment may result in effective prevention of RA development at a pre-arthritic stage. Thus, further efforts need to be taken in detecting and treating tenosynovitis in the pre-RA stage, which can be facilitated by ultrasonography and magnetic resonance imaging.
No takes yet. Share an insight, caveat, or question.
Izumiyama et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: